论文部分内容阅读
目的观察盐酸纳美芬治疗儿童重症病毒性脑炎的疗效。方法将156例符合诊断标准的儿童重症病毒性脑炎的患儿随机分成AB两组,A组76例,B组80例。在相同综合治疗及使用抗病毒药病毒唑10~15 mg/(Kg.d)基础上,治疗组(A组)加用盐酸纳美芬治疗0.1 mg/kg,观察患儿用药后症状、体征改善情况及预后。结果盐酸纳美芬组治疗儿童重症病毒性脑炎,头痛、呕吐、抽搐、意识恢复及后遗症发生率等方面明显优于对照组,两组比较差异有统计学意义(P<0.01)。结论盐酸纳美芬治疗儿童重症病毒性脑炎疗效显著,作用迅速,安全性好,不良反应少,值得临床推广。
Objective To observe the curative effect of nalmefene hydrochloride in children with severe viral encephalitis. Methods A total of 156 children with severe viral encephalitis who met the diagnostic criteria were randomly divided into two groups: A group (76 cases) and B group (80 cases). On the basis of the same comprehensive treatment and the use of the antiviral ribavirin 10 ~ 15 mg / (Kg.d), the treatment group (group A) plus nalmefene hydrochloride was treated with 0.1 mg / kg, and the symptoms and signs Improve the situation and prognosis. Results Nalmefene hydrochloride group was significantly better than the control group in treating children with severe viral encephalitis, headache, vomiting, convulsions, consciousness recovery and the incidence of sequelae, the difference was statistically significant (P <0.01). Conclusion Nalmefene hydrochloride has a significant therapeutic effect on children with severe viral encephalitis, its effect is rapid, its safety is good and its adverse reactions are few. It is worthy of clinical promotion.